Directly Compressible Granules

Directly Compressible Granules
Product Description

1. Aceclofenac Granules 50%2. Clopidogrel Granules 60% 3. Fexofenadine Granules 48% 4. Gliclazide Granules SR 48% 5. Levitiracetam Granules SR 75%, 80% 6. Lisinopril Granules 50% 7. Metformin HCL Granules IR 86.66%, 93% 8. Metformin HCL Granules SR 75%, 80% 9. Montelukast Granules 7.1% 10. Paracetamol Granules 83%, 90%, 96% 11. Sildenafil Citrate Granules 25% 12. Sitagliptin Granules 25.3% 13. Tadalafil Granules 20% 14. Telmisartan Granules 20% 15. Valproic acid Granules SR 66.7% 16. Vildagliptin Granules 25.3%

Read more Show less

YSK Laboratories Pvt Ltd

  • IN
  • 2023
    On CPHI since
  • 1 - 24
    Employees
Company types
Manufacturer/Innovator
Primary activities
Pharmaceutical Company (generic finished products)
Pharmaceutical Company (innovator finished products)
View company profile
Categories
more categories Show less
Specifications
  • Supplied from
    India
More specifications Fewer specifications
Sales Markets
Show more Show less

YSK Laboratories Pvt Ltd

  • IN
  • 2023
    On CPHI since
  • 1 - 24
    Employees
Company types
Manufacturer/Innovator
Primary activities
Pharmaceutical Company (generic finished products)
Pharmaceutical Company (innovator finished products)
View company profile

More Products from YSK Laboratories Pvt Ltd (3)

YSK Laboratories Pvt Ltd resources (9)

  • YSK Labs - CCD partners Watchlist 2023

    News YSK Labs - CCD partners Watchlist 2023

    YSK Labs was featured on the CCD partners Watchlist 2023 aimed to highlight the profile of Innovative and disruptive Startup companies participating in the CPHI Startup Market 2023. This Watchlist is designed to capture and track exciting up-and-coming businesses with the potential to disrupt the pharmaceutical industry. 

    Out of approximately 1000+ companies in over 57 countries, YSK Labs was amongst the 21 companies selected and featured. 
    14 Sep 2023
  • DC Granules Product List

    Brochure DC Granules Product List

    DC Granules Product List
  • Finished Formulations Product List

    Brochure Finished Formulations Product List

    Finished Formulations Product List
  • YSK Labs Company Brochure

    Brochure YSK Labs Company Brochure

    YSK Labs Company Brochure
  • YSK Labs Advantages of DC Granules

    Brochure YSK Labs Advantages of DC Granules

    Advantages of DC Granules vs API
  • YSK Brochure 1

    Brochure YSK Brochure 1

  • YSK Directly Compressible Granule (DC) Product List

    Brochure YSK Directly Compressible Granule (DC) Product List

  • YSK Watchlist 2023 by CCD Partners

    Brochure YSK Watchlist 2023 by CCD Partners

    We are extremely delighted to announce that YSK Laboratories Pvt Ltd was recently featured in the bespoke Watchlist 2023 by CCD Partners,
  • YSK Laboratories Pvt Ltd Brochure

    Brochure YSK Laboratories Pvt Ltd Brochure

    YSK Laboratories is a distinguished R&D company with an integrated manufacturing facility near Mumbai specializing in producing innovative pharmaceutical solutions, particularly our game-changing DC Granules. These Semi-Formulated APIs can be Directly Compressed into Solid Finished Dosage Forms (Tablets) in just ONE compression step. We take pride in offering Superior Quality: SUSTAINED RELEASE/EXTENDED RELEASE (SR/XR/ER) AND IMMEDIATE RELEASE (IR) PRODUCTS which stand out due to their unique Manufacturing Technologies and Lower Excipient Load. Our state-of-the-art production facilities stand as a testament to our unwavering commitment to quality. We maintain a capacity of 400-500 metric tons of DC Granules annually ensuring uninterrupted innovation, production and adherence to the highest industry standards and stringent norms including USFDA, EU GMP, UK MHRA, TGA & WHO GMP demonstrating our dedication to Quality and Regulatory Compliance.